Bernadette Connaughton


- Role
-
Board member
Elected to the Board in 2019 and regarded as an independent board member.
- Member of the Audit Committee
Special competencies
More than 30 years of global strategic, commercial and leadership expertise, and a broad perspective on the strategy, capabilities and governance required for successful execution in U.S. and international markets.
Current Positions
Board member of Halozyme Therapeutics Inc. and Editas Medicine.